Pancreatic Cancer Research at TGen Gets $18 Million Infusion

How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn't even a brand-name digestive organ, like the kidney or liver. The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed...
Carbonatix Pre-Player Loader

Audio By Carbonatix

How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn’t even a brand-name digestive organ, like the kidney or liver.

The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed nationwide by the Stand Up to Cancer foundation. TGen’s getting $18 million.

What’s great about this foundation is the aim to put research into practice — and make patients well — ASAP. The research conducted by TGen with its share of the gifts will be tried out at Scottsdale Healthcare at Shea hospital.

TGen says its role will be to:

When news happens, Phoenix New Times is there —
Your support strengthens our coverage.

We’re aiming to raise $30,000 by December 31, so we can continue covering what matters most to you. If New Times matters to you, please take action and contribute today, so when news happens, our reporters can be there.

$30,000

Editor's Picks

…launch a series of innovative clinical trials in advanced pancreatic cancer. These clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply.

Sounds like a plan.

GET MORE COVERAGE LIKE THIS

Sign up for the This Week’s Top Stories newsletter to get the latest stories delivered to your inbox

Loading latest posts...